Upperton Pharma Solutions

  • GMP Suite Corridor
About Upperton Pharma Solutions

Upperton Pharma Solutions is a specialist CDMO providing formulation and dosage form development services to the biotechnology and pharmaceutical industries. We offer our clients a complete development service, from early feasibility studies to process optimisation, scale up and clinical trial (GMP/IMP) manufacturing.

  • GB
  • 2019
    On CPHI since
  • 1
    Certificates
  • 100 - 249
    Employees
Company types
CMO/CDMO
Primary activities
Contract Manufacturer
Contract Research Organisation
Contact info
Meet us at

CPHI Frankfurt 2025

Messe, Frankfurt
28 Oct 2025 - 30 Oct 2025

Products from Upperton Pharma Solutions (7)

  • Pulmonary Delivery

    Product Pulmonary Delivery

    Where particle size and performance really matters, Upperton have the expertise.
    Drug delivery into the lung is one of the fastest growing, yet technically challenging areas of pharmaceutical development. Producing a successful pulmonary drug product requires expertise in formulation development, part...
  • UpperNose™

    Product UpperNose™

    The ability to self-administer small molecules, biologics and vaccines is highly attractive yet the knowledge and expertise necessary to rapidly develop products for this delivery route remains limited in the CDMO space. To meet this growing demand, Upperton has developed UpperNose™, a unique nasal product...
  • Contract Development and Manufacturing

    Product Contract Development and Manufacturing

    Upperton Pharma Solutions is an early phase Pharmaceutical Contract Development and Manufacturing Organisation (CDMO) with more than twenty years of experience in the development of pharmaceutical dosage forms.
    We offer our clients an extensive range of services, from early feasibility to dosage form ...
  • Oral Dosage Forms

    Product Oral Dosage Forms

    We have extensive experience and know-how in the development of oral dosage forms containing spray dried powders. Tablets and capsules are the most common dry powder dosage form. However, other dosage forms such as sachets (bulk powders), vials (for reconstitution) have also be developed by the Upperton team.
  • Inhalation Delivery

    Product Inhalation Delivery

    There is interest in delivering molecules via devices (inhalation and nasal). Use our knowledge to engineer particles containing your drug with optimal aerodynamic properties tailored to the delivery device.
  • Analytical Techniques

    Product Analytical Techniques

    Comprehensive analysis during formulation development and GMP manufacture is vital to ensure that your drug has optimal delivery properties and stability profile as well as supporting your regulatory submissions.
  • Spray Drying

    Product Spray Drying

    We have been successfully developing spray dried formulations for our customers for more than twenty years. Our experience spans a vast range of therapeutics from small molecule API’s to even the most sensitive and complex biologicals.

Upperton Pharma Solutions Resources (1)